Will the Novo-Catalent merger be challenged under the new Trump administration? A former FTC policy director thinks so.

The growing inclination for biologics and biosimilars is driving the sterile injectable contract manufacturing market.New York, USA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Market Overview: Polaris Market ...

Pharma leaders hoping for a friendlier merger environment after the Trump administration grabs the keys to the White House ...

The Swiss aseptic fill-finish manufacturing specialist Baccinex has become the latest in a string of acquisitions by the ...

Pharmaceutical contract manufacturing is when a company hires a third-party to produce drugs for them. The report by ...

Novo Nordisk faces challenges in weight-loss sector, but acquisition and strong diabetes portfolio position it for future ...

Novo Nordisk A/S is cutting back on recruiting in Denmark after reaching the limits of its home country’s labor market in the ...

European stock markets closed lower in Tuesday trading as the Stoxx Europe was down 0.57%, Germany's DAX dropped 0.56%, the FTSE in London fell 0.40%, France's CAC lost 0.87%, and the Swiss Market ...

Chris Senyek, chief investment strategist at Wolfe Research, published his list of stocks with the greatest number of ...

Lockheed Martin has felt financial strain as early funding for the upcoming F-35 jets dried up, but kept working on them to avoid supply chain disruptions.

A Congress MLA in Karnataka has asked Chief Minister Siddaramaiah to cancel some election guarantees, flagging a lack of funds, which has left the state government red-faced.

Opinion writers tackle these public health issues.